| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |